BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25564218)

  • 1. Clinical predictors of early cancer-related mortality following neoadjuvant therapy and oesophagectomy.
    Stiles BM; Salzler GG; Nasar A; Paul S; Lee PC; Port JL; Altorki NK
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):455-60; discussion 460-1. PubMed ID: 25564218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.
    Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR
    Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy.
    Stiles BM; Nasar A; Mirza FA; Lee PC; Paul S; Port JL; Altorki NK
    Eur J Cardiothorac Surg; 2012 Oct; 42(4):659-64. PubMed ID: 22491667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence.
    Lagarde SM; Phillips AW; Navidi M; Disep B; Immanuel A; Griffin SM
    Br J Cancer; 2015 Nov; 113(10):1427-33. PubMed ID: 26554656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinoscopy-assisted oesophagectomy in T1 oesophageal cancer patients with serious comorbidities: a 5-year long-term follow-up.
    Wang J; Jiang NQ; Jiang B; Wang ZL; Zhang XY
    Interact Cardiovasc Thorac Surg; 2015 Apr; 20(4):477-81. PubMed ID: 25535180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.
    Bartels H; Stein HJ; Siewert JR
    Br J Surg; 1998 Jun; 85(6):840-4. PubMed ID: 9667720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
    ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer.
    Watanabe M; Baba Y; Yoshida N; Ishimoto T; Nagai Y; Iwatsuki M; Iwagami S; Baba H
    Ann Surg Oncol; 2014 Sep; 21(9):2838-44. PubMed ID: 24715216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a new approach for mortality risk assessment in oesophagectomy for cancer based on age- and gender-corrected body mass index.
    Van Veer H; Moons J; Darling G; Lerut T; Coosemans W; Waddell T; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2015 Oct; 48(4):600-7. PubMed ID: 25564215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy followed by surgery for advanced oesophageal cancer.
    Toxopeus EL; Talman S; van der Gaast A; Spaander VM; van Rij CM; Krak NC; Biermann K; Tilanus HW; Mathijssen RH; van Lanschot JJ; Wijnhoven BP
    Eur J Surg Oncol; 2015 Mar; 41(3):323-32. PubMed ID: 25534280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Disease Recurrence and Survival in Esophageal Adenocarcinomas With Complete Response to Neoadjuvant Therapy.
    Agoston AT; Zheng Y; Bueno R; Lauwers GY; Odze RD; Srivastava A
    Am J Surg Pathol; 2015 Aug; 39(8):1085-92. PubMed ID: 26076061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?
    Fogh SE; Yu A; Kubicek GJ; Scott W; Mitchell E; Rosato EL; Berger AC
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1372-6. PubMed ID: 21106309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer.
    Markar SR; Bodnar A; Rosales J; Song G; Low DE
    Ann Surg Oncol; 2013 Nov; 20(12):3935-41. PubMed ID: 23892525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving decision-making regarding oesophagectomy after preoperative therapy.
    Kidane B; Darling GE
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):461-2. PubMed ID: 25564210
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma.
    Lee PC; Mirza FM; Port JL; Stiles BM; Paul S; Christos P; Altorki NK
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1196-206. PubMed ID: 21397267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
    Fréchette E; Buck DA; Kaplan BJ; Chung TD; Shaw JE; Kachnic LA; Neifeld JP
    J Surg Oncol; 2004 Aug; 87(2):68-74. PubMed ID: 15282698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
    Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
    J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.